Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Corrigendum to "TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer" [Canc. Lett. 412 (2018) 155-169].

Bogusławska J, Rodzik K, Popławski P, Kędzierska H, Rybicka B, Sokół E, Tański Z, Piekiełko-Witkowska A.

Cancer Lett. 2020 Jan 28. pii: S0304-3835(20)30014-8. doi: 10.1016/j.canlet.2020.01.006. [Epub ahead of print] No abstract available.

PMID:
32005526
2.

MicroRNA-Mediated Metabolic Reprograming in Renal Cancer.

Bogusławska J, Popławski P, Alseekh S, Koblowska M, Iwanicka-Nowicka R, Rybicka B, Kędzierska H, Głuchowska K, Hanusek K, Tański Z, Fernie AR, Piekiełko-Witkowska A.

Cancers (Basel). 2019 Nov 20;11(12). pii: E1825. doi: 10.3390/cancers11121825.

3.

Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.

Marusiak AA, Prelowska MK, Mehlich D, Lazniewski M, Kaminska K, Gorczynski A, Korwat A, Sokolowska O, Kedzierska H, Golab J, Biernat W, Plewczynski D, Brognard J, Nowis D.

Oncogene. 2019 Apr;38(15):2860-2875. doi: 10.1038/s41388-018-0618-0. Epub 2018 Dec 14.

4.

microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3'UTRs.

Sokół E, Kędzierska H, Czubaty A, Rybicka B, Rodzik K, Tański Z, Bogusławska J, Piekiełko-Witkowska A.

Exp Cell Res. 2018 Feb 15;363(2):208-217. doi: 10.1016/j.yexcr.2018.01.009. Epub 2018 Jan 10.

PMID:
29331391
5.

TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer.

Bogusławska J, Rodzik K, Popławski P, Kędzierska H, Rybicka B, Sokół E, Tański Z, Piekiełko-Witkowska A.

Cancer Lett. 2018 Jan 1;412:155-169. doi: 10.1016/j.canlet.2017.10.019. Epub 2017 Oct 25. Erratum in: Cancer Lett. 2020 Jan 28;:.

PMID:
29079415
6.

Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.

Kędzierska H, Piekiełko-Witkowska A.

Cancer Lett. 2017 Jun 28;396:53-65. doi: 10.1016/j.canlet.2017.03.013. Epub 2017 Mar 14. Review.

PMID:
28315432
7.

Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.

Kędzierska H, Popławski P, Hoser G, Rybicka B, Rodzik K, Sokół E, Bogusławska J, Tański Z, Fogtman A, Koblowska M, Piekiełko-Witkowska A.

Int J Mol Sci. 2016 Sep 28;17(10). pii: E1598.

8.

Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer.

Boguslawska J, Kedzierska H, Poplawski P, Rybicka B, Tanski Z, Piekielko-Witkowska A.

J Urol. 2016 Jun;195(6):1892-902. doi: 10.1016/j.juro.2015.11.050. Epub 2015 Nov 26.

PMID:
26631499
9.

Epigenetic regulation of thyroid hormone receptor beta in renal cancer.

Wojcicka A, Piekielko-Witkowska A, Kedzierska H, Rybicka B, Poplawski P, Boguslawska J, Master A, Nauman A.

PLoS One. 2014 May 21;9(5):e97624. doi: 10.1371/journal.pone.0097624. eCollection 2014.

10.

Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.

Piekielko-Witkowska A, Kedzierska H, Poplawski P, Wojcicka A, Rybicka B, Maksymowicz M, Grajkowska W, Matyja E, Mandat T, Bonicki W, Nauman P.

Biochim Biophys Acta. 2013 Jun;1832(6):763-72. doi: 10.1016/j.bbadis.2013.02.013. Epub 2013 Feb 24.

Supplemental Content

Loading ...
Support Center